Meloxicam and Xeljanz drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Meloxicam and Xeljanz together. This study is created by eHealthMe based on reports of 670 people who take Meloxicam and Xeljanz from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on meloxicam and tofacitinib citrate (the active ingredients of Meloxicam and Xeljanz, respectively), and Meloxicam and Xeljanz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 33,162 users)

What is Xeljanz?

Xeljanz has active ingredients of tofacitinib citrate. It is often used in rheumatoid arthritis. (latest outcomes from Xeljanz 57,356 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 08, 2019

670 people who take Meloxicam, Xeljanz are studied.


Number of reports submitted per year:

Meloxicam and Xeljanz drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Sinusitis (inflammation of sinus)
  2. Diarrhoea
  3. Nausea (feeling of having an urge to vomit)
  4. Asthenia (weakness)
  5. Drug ineffective
  6. Gait disturbance
  7. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Abdominal discomfort
  10. Abdominal pain upper
1 - 6 months:
  1. Arthralgia (joint pain)
  2. Sinusitis (inflammation of sinus)
  3. Urinary tract infection
  4. Drug ineffective
  5. Cough
  6. Infection
  7. Nausea (feeling of having an urge to vomit)
  8. Pyrexia (fever)
  9. Upper respiratory tract infection
  10. Malaise (a feeling of general discomfort or uneasiness)
6 - 12 months:
  1. Drug ineffective
  2. Sinusitis (inflammation of sinus)
  3. Arthralgia (joint pain)
  4. Abdominal discomfort
  5. Arthropathy
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Dyspnoea (difficult or laboured respiration)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Anxiety
  10. Blood creatinine increased
1 - 2 years:
  1. Dyspepsia (indigestion)
  2. Erythema (redness of the skin)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Fibromyalgia (a long-term condition which causes pain all over the body)
  6. Finger deformity (a deformed position of the finger)
  7. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  8. Hair disorder
  9. Hand deformity
  10. Hypersensitivity
2 - 5 years:
  1. Pneumonia
  2. Abdominal pain
  3. Drug ineffective
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Cough
  6. Cyst (a closed sac)
  7. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  8. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  9. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  10. Vomiting
5 - 10 years:
  1. Red blood cell count decreased
  2. Abdominal discomfort
  3. Abdominal pain
  4. Alopecia (absence of hair from areas of the body)
  5. Asthenia (weakness)
  6. Body temperature increased
  7. Chest pain
  8. Cystitis (inflammation of the wall of the bladder)
  9. Dizziness
  10. Dyspepsia (indigestion)
10+ years:
  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Influenza
  3. Mobility decreased (ability to move is reduced)
  4. Photosensitivity reaction
  5. Purpura (purplish discoloration of the skin)
not specified:
  1. Drug ineffective
  2. Arthralgia (joint pain)
  3. Peripheral swelling
  4. Pain in extremity
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nausea (feeling of having an urge to vomit)
  8. Joint swelling
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Pneumonia

Most common drug interactions by gender *:

female:
  1. Sinusitis (inflammation of sinus)
  2. Drug effect decreased
  3. Dyspnoea (difficult or laboured respiration)
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Pneumonia
  6. Condition
  7. Headache (pain in head)
  8. Cough
  9. Dizziness
  10. Rash
male:
  1. Drug ineffective
  2. Pneumonia
  3. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  4. Dry skin
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Oropharyngeal pain
  7. Sinusitis (inflammation of sinus)
  8. Abdominal discomfort
  9. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  10. Cough

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Decreased appetite
  2. Headache (pain in head)
  3. Hepatic enzyme increased
  4. Interstitial lung disease
  5. Lacrimation increased
  6. Mood swings (an extreme or rapid change in mood)
  7. Ocular hyperaemia (an abnormally large amount of blood in eye)
  8. Photophobia (extreme sensitivity to light)
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Adverse reaction
20-29:
  1. Asthenia (weakness)
  2. Condition
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Dizziness
  5. Drug ineffective
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
30-39:
  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Conjunctivitis (pink eye)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Sinusitis (inflammation of sinus)
  5. Cellulitis (infection under the skin)
  6. Pain in extremity
  7. Drug ineffective
  8. Facial pain
  9. Headache (pain in head)
  10. Hypersensitivity
40-49:
  1. Nausea (feeling of having an urge to vomit)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Pain in extremity
  4. Infection
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Nodule (a small rock or mineral cluster)
  7. Joint swelling
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Erythema (redness of the skin)
50-59:
  1. Pyrexia (fever)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Peripheral swelling
  4. Dizziness
  5. Abdominal discomfort
  6. Diarrhoea
  7. Gait disturbance
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Pain in extremity
  10. Upper respiratory tract infection
60+:
  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Cough
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Condition
  6. Diarrhoea
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Arthropathy
  9. Influenza
  10. Joint swelling

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Xeljanz?


You are not alone:




Related publications that referenced our studies

Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Meloxicam and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Xeljanz and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Meloxicam and Xeljanz
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Meloxicam and Xeljanz



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!